The prognostic value of the nodal ratio in N1 breast cancer

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Han, Tae Jin ^a   Kang, Eun Young ^a   Jeon, Wan ^a   Kim, Sung Won ^a   Kim, Jee Hyun ^a   Kim, Yu Jung ^a   Park, So Yeon ^a   Kim, Jae Sung ^a   Kim, In Ah ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Breast cancer; N1; Nodal ratio; Prognostic factor

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE; BREAST TUMOR; CANCER INVASION; FEMALE; LYMPH NODE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RADIOTHERAPY; RECURRENT DISEASE; RISK;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RECURRENCE; RETROSPECTIVE STUDIES; RISK;

EID: 80053536625     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717x-6-131     Document Type: Article

References (31)

1. Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, Storme G: Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol 2003, 22:697-704.
2. American Joint Committee on Cancer: Chapter 32. Breast. AJCC cancer staging manual. 7 edition. New York: Springer; 2010, 347-369.
3. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG, American Society of Clinical Oncology: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1539-1569.
4. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, Vlastos G, Wallace AM, Hortobagyi GN, Nieto Y: Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 2006, 24:2910-2916.
5. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA: The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005, 103:2006-2014.
6. Tai P, Joseph K, Sadikov E, Mahmood S, Lien F, Yu E: Nodal ratios in nodepositive breast cancer-long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68:662-666.
7. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA: The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2007, 68:59-65.
8. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C: Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 2009, 27:1062-1068.
9. Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI: Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol 2009, 16:3388-3395.
10. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr: Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg 2010, 210:797-805.
11. Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB: Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg 2011, 213:45-52.
12. Chagpar AB, Camp RL, Rimm DL: Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer. Ann Surg Oncol .
13. Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, Jung SS, Park HY: Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat .
14. Fortin A, Dagnault A, Blondeau L, Vu TT, Larochelle M: The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation. Int J Radiat Oncol Biol Phys 2006, 65:33-39.
15. Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA: Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:357-364.
16. Wallgren A, Bonetti M, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Thürlimann B, Fey M, Werner ID, Forbes JF, Price K, Coates AS, Collins J: Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 2006, 24:2028-2037.
17. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD: The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001, 50:735-742.
18. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. Int J Radiat Oncol Biol Phys 2001, 50:735-742.
19. Yang PS, Chen CM, Liu MC, Jian JM, Horng CF, Liu MJ, Yu BL, Lee MY, Chi CW: Radiotherapy Can Decrease Locoregional Recurrence and Increase Survival in Mastectomy Patients with T1 to T2 Breast Cancer and One to Three Positive Nodes with Negative Estrogen Receptor and Positive Lymphovascular Invasion Status. Int J Radiat Oncol Biol Phys 2010, 77:516-522.
20. Recht A, Gray R, Davidson NE: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999, 17:1689-1700.
21. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD: Locoregional recurrence patterns after mastectomy and doxorubicinbased chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000, 18:2817-2827.
22. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA: Locoregional recurrence after doxorubicinbased chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 2003, 57:336-344.
23. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E: Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:1337-1347.
24. Lukens JN, Vapiwala N, Hwang WT, Solin LJ: Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. Int J Radiat Oncol Biol Phys 2009, 73:1475-1481.
25. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH: Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 2008, 71:1022-1027.
26. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000, 18:1220-1229.
27. Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24:2028-2037.
28. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
29. Olivotto IA, Chua B, Elliott EA, Parda DS, Pierce LJ, Shepherd L, Vallow LA, White JR, Whelan TJ: A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. Clin Breast Cancer 2003, 4:361-363.
30. Joslyn SA, Konety BR: Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treatment 2005, 91:11-18.
31. Fowble B: Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue. Semin Radiat Oncol 1999, 9:230-240.